Lipid requirements for leukocyte chemotaxis and phagocytosis: effects of inhibitors of phospholipid and cholesterol synthesis.
D000818:Animals; D002633:Chemotaxis / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D002784:Cholesterol / Q000096:biosynthesis*; D002994:Clofibrate / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D050356:Lipid Metabolism; D008264:Macrophages / Q000187:drug effects; D009000:Monocytes / Q000187:drug effects; D010587:Phagocytosis / Q000187:drug effects*; D010743:Phospholipids / Q000037:antagonists & inhibitors*; D014176:Protein Biosynthesis; D014308:Triparanol / Q000494:pharmacology
D010743:Phospholipids; D014308:Triparanol; D002784:Cholesterol; D002994:Clofibrate